健康同卵双胞胎与IBD双胞胎及无关患者共享肠道微生物组特征
本研究对99名双胞胎(51对)、495名健康对照及99名无关IBD患者进行粪便宏基因组测序,发现健康共双胞胎与IBD双胞胎之间物种和通路相对丰度无显著差异;与健康对照相比,健康共双胞胎、IBD双胞胎及无关患者分别有13、19、18种物种和78、105、153条通路差异丰富,且健康共双胞胎与IBD双胞胎共享8/19种物种和37/105条通路。结论认为健康共双胞胎的肠道微生物组呈现IBD样特征,可能先于IBD发病。
要点
- 健康共双胞胎与IBD双胞胎的肠道物种和通路相对丰度无显著差异(FDR<0.10)。
- 健康共双胞胎与IBD双胞胎共享8/19种差异物种和37/105条差异通路。
- 共享通路包括丙酸降解和L-精氨酸降解等潜在炎症相关通路。
核心结论
- 健康共双胞胎的肠道微生物组呈现IBD样特征,可能先于IBD发病,但需纵向随访推断因果关系。
研究设计与样本
- 研究纳入99名双胞胎(51对)、495名健康年龄性别BMI匹配对照及99名无关IBD患者,进行全基因组宏基因组鸟枪法测序,用多变量广义线性模型比较分类和功能组成。
主要发现
- 健康共双胞胎与IBD双胞胎之间物种和通路相对丰度无显著差异(FDR<0.10)。
- 与健康对照相比,健康共双胞胎、IBD双胞胎和无关IBD患者分别有13、19和18种物种差异丰富(FDR<0.10)。
- 与健康对照相比,健康共双胞胎、IBD双胞胎和无关IBD患者分别有78、105和153条通路差异丰富(FDR<0.10)。
- 健康共双胞胎与IBD双胞胎共享8/19种(42.1%)和1/18种(5.6%)差异物种,共享37/105条(35.2%)和30/153条(19.6%)差异通路。
- 共享通路包括丙酸降解和L-精氨酸降解等潜在炎症相关通路。
临床怎么用
- 对于IBD患者的健康共双胞胎,可关注其肠道微生物组是否呈现IBD样特征,作为潜在风险监测的参考。
局限性
- 原文指出需纵向随访研究以推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: It is currently unclear whether reported changes in the gut microbiome are cause or consequence of inflammatory bowel disease (IBD). Therefore, we studied the gut microbiome of IBD-discordant and -concordant twin pairs, which offers the unique opportunity to assess individuals at increased risk of developing IBD, namely healthy cotwins from IBD-discordant twin pairs. METHODS: Fecal samples were obtained from 99 twins (belonging to 51 twin pairs), 495 healthy age-, sex-, and body mass index-matched controls, and 99 unrelated patients with IBD. Whole-genome metagenomic shotgun sequencing was performed. Taxonomic and functional (pathways) composition was compared among healthy cotwins, IBD-twins, unrelated patients with IBD, and healthy controls with multivariable (ie, adjusted for potential confounding) generalized linear models. RESULTS: No significant differences were observed in the relative abundance of species and pathways between healthy cotwins and their IBD-twins (false discovery rate <0.10). Compared with healthy controls, 13, 19, and 18 species, and 78, 105, and 153 pathways were found to be differentially abundant in healthy cotwins, IBD-twins, and unrelated patients with IBD, respectively (false discovery rate <0.10). Of these, 8 (42.1%) of 19 and 1 (5.6%) of 18 species, and 37 (35.2%) of 105 and 30 (19.6%) of 153 pathways overlapped between healthy cotwins and IBD-twins, and healthy cotwins and unrelated patients with IBD, respectively. Many of the shared species and pathways have previously been associated with IBD. The shared pathways include potentially inflammation-related pathways, for example, an increase in propionate degradation and L-arginine degradation pathways. CONCLUSIONS: The gut microbiome of healthy cotwins from IBD-discordant twin pairs displays IBD-like signatures. These IBD-like microbiome signatures might precede the onset of IBD. However, longitudinal follow-up studies are needed to infer a causal relationship.
引用
- Brand EC, Klaassen MAY, Gacesa R, et al. Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients. Gastroenterology. 2021. PMID: 33476671. doi:10.1053/j.gastro.2021.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。